Xenon Pharma’s azetukalner shows 53% seizure reduction in trial



[
Xenon Pharma’s azetukalner shows 53% seizure reduction in trial
[og_img]
https://www.investing.com/news/company-news/xenon-pharmas-azetukalner-shows-53-seizure-reduction-in-trial-93CH-4622259


Investing.com

Latest articles

spot_imgspot_img

Related articles

Leave a reply

Please enter your comment!
Please enter your name here

spot_imgspot_img